The Center for Reproductive Care under Dr. Mary Wood Molo is located at 1725 W Harrison St, Suite 408E, on the campus of Rush University Medical Center in Chicago's Near West Side. This placement within one of Chicago's leading academic medical centers gives the practice access to multidisciplinary consultation, hospital-based surgical suites, and integration with oncology, gynecologic surgery, and maternal-fetal medicine. Dr. Molo is a long-established figure in Chicago reproductive medicine with a particular emphasis on fertility preservation and oncofertility — making this practice a frequent destination for patients referred from Rush's cancer care programs. For a broader view of fertility care throughout the state, see the Illinois fertility clinics directory.
Physicians and Clinical Team
Dr. Mary Wood Molo is a board-certified reproductive endocrinologist and infertility specialist with faculty status at Rush Medical College. Her academic and clinical focus includes fertility preservation for cancer patients, recurrent pregnancy loss, and complex IVF cases. The Center for Reproductive Care operates within the broader Rush University Medical Center framework, giving the team the ability to coordinate with oncologists, hematologists, and surgical subspecialists housed in the same institution. Support staff includes experienced reproductive nurses, an embryology team, and administrative staff familiar with navigating Illinois insurance mandates.
Services and Treatments
- IVF with fresh and frozen embryo transfer
- ICSI for male factor infertility
- Preimplantation genetic testing (PGT-A, PGT-M)
- Egg cryopreservation for elective and medical fertility preservation
- Embryo cryopreservation
- Oncofertility: urgent egg and embryo banking before cancer treatment
- Intrauterine insemination (IUI)
- Donor egg and donor sperm cycles
- Gestational carrier coordination
- Ovulation induction and monitoring
- Recurrent pregnancy loss evaluation
- Surgical treatment for uterine and tubal pathology
- LGBTQ+ family-building services
Laboratory and Success Rates
The Center for Reproductive Care operates within the Rush University Medical Center system, which maintains CLIA-certified laboratory infrastructure and oversight consistent with an academic medical center. Oncofertility patients often require expedited stimulation protocols, and the team has experience managing compressed timelines without compromising laboratory quality. Patients should review the most current cycle-level data published by the CDC's ART Surveillance program and the SART Clinic Summary Report.
Patient Experience
Rush University Medical Center is a large, complex campus on the Near West Side of Chicago, well-served by the CTA Pink and Green lines at the Medical Center station. Patients who are already receiving care at Rush — for cancer, autoimmune conditions, or other systemic diagnoses — often find the co-location of fertility services with their other providers to be a meaningful advantage. Parking is available in Rush's medical campus garages, and the area is accessible from the Eisenhower Expressway. Patients coming specifically for fertility care (not referred from within Rush) should expect a large academic medical center environment, which some find reassuring and others find less intimate than a boutique fertility clinic.
Considering At-Home Insemination?
Not every fertility journey begins in a clinic. At-home intracervical insemination (ICI) is a lower-cost, private option that suits patients with no known fertility diagnosis — including single parents by choice, same-sex couples, and people who want to try a few cycles before committing to clinical treatment.
At-home insemination kits like those from MakeAMom come with step-by-step instructions designed for donor or partner sperm. Kits are a one-time purchase that can be reused until conception succeeds, require no clinic visit, and arrive in plain, discreet packaging. Many patients use them as a first step while working toward a fertility consultation — or alongside ovulation tracking while they wait for an appointment slot.
If you have a known fertility diagnosis, have been trying for 12 months without success (six months if you're over 35), or your physician has already recommended IUI or IVF, a board-certified reproductive endocrinologist is the right next step.
Insurance and Financing
Illinois has one of the strongest IVF insurance mandates in the country. Insurers covering more than 25 employees are required to provide coverage for IVF and other fertility treatments. Rush University Medical Center participates with major commercial insurers and is experienced helping patients navigate the Illinois mandate. Patients should confirm in-network status, cycle limits, and medication coverage with their specific insurer. For patients without IVF coverage, the financial counselors at Rush can provide cost estimates and discuss self-pay options.
Frequently Asked Questions
What is oncofertility and is it available here? Oncofertility refers to fertility preservation for patients about to undergo cancer treatment that may impair future fertility — typically chemotherapy, radiation, or surgery. Dr. Molo has a long research and clinical history in this area. Rush's cancer center can provide same-building referrals, and the team has experience completing egg or embryo banking on accelerated timelines to fit cancer treatment schedules.
Does Illinois insurance mandate cover fertility preservation for cancer patients? Illinois law requires coverage for fertility preservation services when a medical condition or its treatment may iatrogenically impair fertility. Patients should verify with their insurer whether this provision applies to their specific plan.
Can I be seen at this practice if I'm not a Rush patient? Yes. While many patients are referred from within the Rush system, new patients from outside Rush are welcome for fertility consultations. Contact the practice directly to discuss scheduling and intake requirements.
Is PGT-A recommended for all IVF patients? PGT-A (preimplantation genetic testing for aneuploidies) is not universally recommended but is often discussed for patients over 35, those with prior IVF failures, or those with recurrent pregnancy loss. Your physician will discuss whether it is appropriate for your individual case.